38360971|t|Ripa-56 protects retinal ganglion cells in glutamate-induced retinal excitotoxic model of glaucoma.
38360971|a|Glaucoma is a prevalent cause of blindness globally, characterized by the progressive degeneration of retinal ganglion cells (RGCs). Among various factors, glutamate excitotoxicity stands out as a significant contributor of RGCs loss in glaucoma. Our study focused on Ripa-56 and its protective effect against NMDA-induced retinal damage in mice, aiming to delve into the potential underlying mechanism. The R28 cells were categorized into four groups: glutamate (Glu), Glu + Ripa-56, Ripa-56 and Control group. After 24 h of treatment, cell death was assessed by PI / Hoechst staining. Mitochondrial membrane potential changes, apoptosis and reactive oxygen species (ROS) production were analyzed using flow cytometry. The alterations in the expression of RIP-1, p-MLKL, Bcl-2, BAX, Caspase-3, Gpx4 and SLC7A11 were examined using western blot analysis. C57BL/6j mice were randomly divided into NMDA, NMDA + Ripa-56, Ripa-56 and control groups. Histological changes in the retina were evaluated using hematoxylin and eosin (H&E) staining. RGCs survival and the protein expression changes of RIP-1, Caspase-3, Bcl-2, Gpx4 and SLC7A11 were observed using immunofluorescence. Ripa-56 exhibited a significant reduction in the levels of RIP-1, p-MLKL, Caspase-3, and BAX induced by glutamate, while promoting the expression of Bcl-2, Gpx-4, and SLC7A1 in the Ripa-56-treated group. In our study, using an NMDA-induced normal tension glaucoma mice model, we employed immunofluorescence and H&E staining to observe that Ripa-56 treatment effectively ameliorated retinal ganglion cell loss, mitigating the decrease in retinal ganglion cell layer and bipolar cell layer thickness caused by NMDA. In this study, we have observed that Ripa-56 possesses remarkable anti- necroptotic, anti-apoptotic and anti-ferroptosis properties. It demonstrates the ability to combat not only glutamate-induced excitotoxicity in R28 cells, but also NMDA-induced retinal excitotoxicity in mice. Therefore, Ripa-56 could be used as a potential retinal protective agent.
38360971	0	7	Ripa-56	Chemical	-
38360971	25	33	ganglion	Disease	MESH:D045888
38360971	43	52	glutamate	Chemical	MESH:D018698
38360971	61	80	retinal excitotoxic	Disease	MESH:D012173
38360971	90	98	glaucoma	Disease	MESH:D005901
38360971	100	108	Glaucoma	Disease	MESH:D005901
38360971	133	142	blindness	Disease	MESH:D001766
38360971	210	218	ganglion	Disease	MESH:D045888
38360971	256	265	glutamate	Chemical	MESH:D018698
38360971	266	280	excitotoxicity	Disease	
38360971	337	345	glaucoma	Disease	MESH:D005901
38360971	368	375	Ripa-56	Chemical	-
38360971	410	414	NMDA	Chemical	MESH:D016202
38360971	423	437	retinal damage	Disease	MESH:D012164
38360971	441	445	mice	Species	10090
38360971	508	511	R28	CellLine	CVCL:D502
38360971	553	562	glutamate	Chemical	MESH:D018698
38360971	564	567	Glu	Chemical	MESH:D018698
38360971	570	573	Glu	Chemical	MESH:D018698
38360971	576	583	Ripa-56	Chemical	-
38360971	585	592	Ripa-56	Chemical	-
38360971	669	676	Hoechst	Chemical	-
38360971	743	766	reactive oxygen species	Chemical	MESH:D017382
38360971	768	771	ROS	Chemical	MESH:D017382
38360971	857	862	RIP-1	Gene	19766
38360971	866	870	MLKL	Gene	74568
38360971	872	877	Bcl-2	Gene	12043
38360971	879	882	BAX	Gene	12028
38360971	884	893	Caspase-3	Gene	12367
38360971	895	899	Gpx4	Gene	625249
38360971	904	911	SLC7A11	Gene	26570
38360971	955	961	C57BL/	CellLine	CVCL:C152
38360971	964	968	mice	Species	10090
38360971	996	1000	NMDA	Chemical	MESH:D016202
38360971	1002	1006	NMDA	Chemical	MESH:D016202
38360971	1009	1016	Ripa-56	Chemical	-
38360971	1018	1025	Ripa-56	Chemical	-
38360971	1102	1113	hematoxylin	Chemical	MESH:D006416
38360971	1118	1123	eosin	Chemical	MESH:D004801
38360971	1125	1128	H&E	Chemical	-
38360971	1192	1197	RIP-1	Gene	19766
38360971	1199	1208	Caspase-3	Gene	12367
38360971	1210	1215	Bcl-2	Gene	12043
38360971	1217	1221	Gpx4	Gene	625249
38360971	1226	1233	SLC7A11	Gene	26570
38360971	1274	1281	Ripa-56	Chemical	-
38360971	1333	1338	RIP-1	Gene	19766
38360971	1342	1346	MLKL	Gene	74568
38360971	1348	1357	Caspase-3	Gene	12367
38360971	1363	1366	BAX	Gene	12028
38360971	1378	1387	glutamate	Chemical	MESH:D018698
38360971	1423	1428	Bcl-2	Gene	12043
38360971	1430	1435	Gpx-4	Gene	625249
38360971	1441	1447	SLC7A1	Gene	11987
38360971	1455	1462	Ripa-56	CellLine	CVCL:C4TM
38360971	1501	1505	NMDA	Chemical	MESH:D016202
38360971	1514	1537	normal tension glaucoma	Disease	MESH:D057066
38360971	1538	1542	mice	Species	10090
38360971	1585	1588	H&E	Chemical	-
38360971	1614	1621	Ripa-56	Chemical	-
38360971	1656	1682	retinal ganglion cell loss	Disease	MESH:D012173
38360971	1719	1727	ganglion	Disease	MESH:D045888
38360971	1782	1786	NMDA	Chemical	MESH:D016202
38360971	1968	1977	glutamate	Chemical	MESH:D018698
38360971	1986	2000	excitotoxicity	Disease	
38360971	2004	2007	R28	CellLine	CVCL:D502
38360971	2024	2028	NMDA	Chemical	MESH:D016202
38360971	2037	2059	retinal excitotoxicity	Disease	MESH:D012173
38360971	2063	2067	mice	Species	10090
38360971	2080	2087	Ripa-56	Chemical	-
38360971	Positive_Correlation	MESH:D016202	MESH:D012164
38360971	Positive_Correlation	MESH:D018698	MESH:D012173
38360971	Positive_Correlation	MESH:D018698	12367
38360971	Association	MESH:D018698	MESH:D005901
38360971	Positive_Correlation	MESH:D018698	19766
38360971	Positive_Correlation	MESH:D016202	MESH:D012173
38360971	Positive_Correlation	MESH:D018698	74568
38360971	Positive_Correlation	MESH:D016202	MESH:D057066
38360971	Positive_Correlation	MESH:D018698	12028

